VENINA ISABEL POCO VIANA LEME DE BARROS
Projetos de Pesquisa
Unidades Organizacionais
Instituto Central, Hospital das Clínicas, Faculdade de Medicina - Médico
LIM/57 - Laboratório de Fisiologia Obstétrica, Hospital das Clínicas, Faculdade de Medicina
LIM/57 - Laboratório de Fisiologia Obstétrica, Hospital das Clínicas, Faculdade de Medicina
18 resultados
Resultados de Busca
Agora exibindo 1 - 10 de 18
conferenceObject Maternal death and Venous Thromboembolism (VTE) in patients admitted in a maternity of high risk: results pre and post application of a risk score(2015) SANTOS, R.; BARROS, V. V.; IGAI, A. K.; FRANCISCO, R. P.; ZUGAIB, M.conferenceObject Descriptive analysis of pregnant women with recurrent fetal death and thrombophilia(2014) ANDRES, M. D. P.; IGAI, A. M. K.; BARROS, V; FRANCISCO, R. P.; ZUGAIB, M.- Obstetric antiphospholipid syndrome(2021) BARROS, Venina Isabel Poco Viana Leme de; IGAI, Ana Maria Kondo; OLIVEIRA, Andre Luiz Malavasi Longo de; TERUCHKIN, Marcelo Melzer; ORSI, Fernanda Andrade
- Risk assessment of venous thromboembolism and thromboprophylaxis in pregnant women hospitalized with cancer: Preliminary results from a risk score(2018) HASE, Eliane Azeka; BARROS, Venina Isabel Poco Viana Leme de; IGAI, Ana Maria Kondo; FRANCISCO, Rossana Pulcinelli Vieira; ZUGAIB, MarceloOBJECTIVES: Hospitalized patients with cancer are at high risk of developing venous thromboembolism, and the risk increases with pregnancy. The aim of this study was to apply a thromboprophylaxis protocol with a venous thromboembolism risk score for hospitalized pregnant women with cancer and to evaluate the effects on maternal morbidity and mortality. METHODS: A longitudinal and prospective study was conducted from December 2014 to July 2016. The venous thromboembolism risk score was modified from the guidelines of the Royal College of Obstetricians and Gynaecologists. Patients were classified as low (score <3) or high risk (score >= 3). The high-risk group received thromboprophylaxis with low-molecular-weight heparin, unless the patient had a contraindication for anticoagulation. One patient could have undergone more than one evaluation. RESULTS: Fifty-two ratings were descriptively analyzed: 34 (65.4%) were classified as high risk, and 28/34 (82.3%) received low-molecular-weight heparin, 1 received unfractionated heparin, and 5 did not receive intervention. Most patients (23/52; 44.2%) had breast cancer. The main risk factors for venous thromboembolism in the high-risk group were chemotherapy (within 6 months; 22/34; 64.7%). No patient exhibited venous thromboembolism, adverse effects of anticoagulation or death up to three months after hospitalization. CONCLUSIONS: Most pregnant women with cancer had a high risk for venous thromboembolism at the time of hospitalization. Breast cancer was the most prevalent cancer, and recent chemotherapy was the main risk factor for anticoagulation. The application of a thromboprophylaxis protocol and determination of a venous thromboembolism risk score for these patients was useful for the prevention of maternal morbidity and mortality due to venous thromboembolism.
conferenceObject Severe infections in pregnancy and the risk of venous thromboembolism (VTE)(2019) BARROS, V. V.; HASE, E. A.; HIGAI, A. M. K.; PEREIRA, P. P.; FRANCISCO, R. P. V.; ZUGAIB, M.- Abnormal uterine bleeding and chronic iron deficiency Number 11-December 2022(2022) BARROS, Venina Viana de; HASE, Eliane Azeka; SALAZAR, Cristiano Caetano; IGAI, Ana Maria Kondo; ORSI, Fernanda Andrade; MARGARIDO, Paulo Francisco Ramos
bookPart Tromboembolismo Venoso(2016) BARROS, Venina Isabel Poço Viana Leme de; BORTOLOTTO, Maria Rita de Figueiredo LemosbookPart Trombose Venosa Profunda e Embolia Pulmonar(2019) BARROS, Venina Isabel Poço Viana Leme deconferenceObject Placental insufficiency resolution with full anticoagulation in patients with prior bad obstetric outcome and dyslipidaemia during pregnancy(2015) SANTOS, R.; BARROS, V. V.; IGAI, A. K.; PULCINELLI, R. F.; ZUGAIB, M.conferenceObject Low levels of vitamin d in pregnant women with thromboembolism/thrombophilia(2013) GALLO, L.; BARROS, V. V.; BAPTISTA, F. S.; BORTOLOTTO, M. R. D. F. L.; V, R. P. Francisco; ZUGAIB, M.